Cooper, Kenneth G.,De Souza, Mark S.,Eubanks, Keith,Starr, David H.,Kapson, John D.,Yang, Hua
申请号：
AU2014269042
公开号：
AU2014269042A1
申请日:
2014.04.24
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
Methods and compositions for treatment of human immunodeficiency virus (HIV) infections have been developed which dampen immune activation with a bias more on the CD4 T cells relative to the CD8 T cell response, inhibit HIV replication, reactivate latent HIV, and inhibit infection of cells by HIV. Pushing latent HIV into active infections with hindrance of cell infection by the reactivated HIV can substantially reduce the number of cells infected with HIV and the viral load of HIV, which is not achieved using just the combination of ART and compounds which activate latent HIV. The methods involve administering to an HIV-infected subject three or more compounds which collectively dampen immune activation with a bias more on the CD4 T cells relative to the CD8 T cell response, inhibit HIV replication, reactivate latent HIV, and inhibiting infection of CD4 T cells by HIV.
